Loading...

Symposium #3

THE REORIENTATION OF SPINE CARE: TREATMENT COLLABORATION FOR COST EFFECTIVE, VALUE PROVEN, PATIENT CENTERED SPINE CARE

Subject overview

LBP was the leading cause of YLDs at 63.7 million in 2019 worldwide. It accounted for approximately 568.4 million prevalent cases and 223.5 million incident cases globally. Although the cost and disability from LBP vary substantially between countries, facts that remain consistent are that costs and disability are rising globally and we are facing greater challenges in managing the impact of the growing economic burden.

Determining value is a challenging proposition for Spine Care providers pitting health care outcomes against expenditures. In a world though, where low back pain accounts for most years lived with disability, value-based care for spinal disorders is of paramount importance. Economic analysis of spine care interventions is critical in determining treatments with proven value. Even when determined, Multidisciplinary efforts at care coordination is necessary to prevent suboptimal isolated treatment recommendations and costly disability. Integrated, collaborative approaches need to continue to be established and built upon to ensure affordable solutions to this growing economic burden

 

Symposium Objective

1) Provide insight into the cost-effectiveness of preventive and therapeutic strategies.
2) Expand Partnerships to aid in understanding the shared dilemma of providing Value Based Spine Care
3) Demonstrate how multidisciplinary collaboration provides a pathway to value by improving outcomes, enhancing patient experience and reducing cost
4) Develop a comprehensive plan and approach to improve health outcomes by providing value-based care
6) Provide the G20 Health Ministers valuable input with regard to cost effective care of Spinal disorders.

 

Topics Highlights

1) The Necessity of Collaboration and Care Coordination in Achieving Value.
2) How Cost Effective, Patient Centered Care, Outcome Driven Care Equates to Value.
3) How the Timing of Treatment has an Impact on Value.
4) Does Value Have the Same Meaning Throughout the World. 

Faculty

CHAIRS

DONNA LAHEY
USA

FRANK KANDZIORA
Germany

SPEAKERS

14.30 – 14.35

Introduction to “Value Based Spine Care”

Donna Lahey, USA

14.35 – 14.47

Pre-requisites for ensuring value in spine care

Omar Alshanqeety, Saudi Arabia

14.47 – 14.59

Multidisciplinary care coordination and Its impact In providing “Value Based Spine Care”

Edward Dohring, USA

14.59 – 15.11

Cost benefit ratio of various treatment options: the cost effectiveness of surgery for cervical myelopathy

Michael Fehlings, USA

15.11 – 15.23

The economic impact of early vs delayed treatment

Cristiano M Menezes, Brazil

15.23 – 15.35

Is High quality low cost spine surgery possible in the developing world

S. Rajasekaran, India

15.35 – 16.00

Panel Discussion

Faculty